February 19, 2019 / 2:41 PM / 2 months ago

BRIEF-Pfizer Receives European Approval For Zirabev, A Biosimilar To Avastin

Feb 19 (Reuters) - Pfizer Inc:

* PFIZER RECEIVES EUROPEAN APPROVAL FOR ZIRABEV (BEVACIZUMAB), A BIOSIMILAR TO AVASTIN

* EC APPROVAL FOR ZIRABEV IS BASED ON A COMPREHENSIVE SUBMISSION PACKAGE WHICH DEMONSTRATED BIOSIMILARITY OF ZIRABEV AND ORIGINATOR PRODUCT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below